|
Development of Tumor Proliferation PET Tracer FLT using a Low Cost Single Dose Automatic Production and Quality Control Biomarker Generator System
|
5R44CA195831-03
|
$711,781
|
|
Bruckbauer, Thomas
|
ABT MOLECULAR IMAGING, INC.
|
|
IeDEA West Africa Renewal 3
|
U01AI069919-12
|
$225,000
|
|
Dabis, Francois
|
ADERA
|
|
Central Africa International Epidemiologic Database to Evaluate AIDS
|
U01AI096299-08
|
$260,000
|
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, IN
|
|
Epigenetic activity of normal and cancer-associated mutant H1 linker histones
|
5F30CA210539-02
|
$44,044
|
|
HEALTON, SEAN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Methylthioadenosine Phosphorylase and AdoMet Synthetase in Cancer
|
5R01CA135405-10
|
$290,592
|
|
SCHRAMM, VERN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Optimization of Non-Ablative Focused Ultrasound Therapy for Tumor Immunity
|
5F30CA200411-04
|
$49,044
|
|
SKALINA, KARIN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Methylome characterization of bronchial epithelial projenitor cells
|
1R21CA209436-01A1
|
$216,172
|
|
SPIVACK, SIMON
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Novel IL-15 Superagonist Therapy for Bladder Cancer
|
2R44CA156740-04
|
$999,919
|
|
WONG, HING
|
ALTOR BIOSCIENCE CORPORATION
|
|
Molecular Biology in Clinical Oncology Workshop
|
5R25CA057732-25
|
$249,978
|
|
SAWYERS, CHARLES
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
Training and Mentorship of Hematologic Oncologists
|
5R25CA168526-05
|
$239,326
|
|
MIKHAEL, JOSEPH
|
AMERICAN SOCIETY OF HEMATOLOGY
|
|
Single Cell Technologies for Rapid Detection of Tumor Heterogeneity
|
5R21CA196460-03
|
$204,524
|
|
ANDERSON, KAREN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Investigation of Biomarkers for Sugars Intake - A Controlled Feeding Study
|
5R01CA197902-03
|
$563,736
|
|
TASEVSKA, NATASHA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
ARF1 signaling in prostate cancer
|
1R56CA204315-01A1
|
$243,960
|
|
WU, GUANGYU
|
AUGUSTA UNIVERSITY
|
|
Proteogenomic Translational Research Center for Clinical Proteomic
|
1U01CA214116-01
|
$1,374,609
|
|
RODLAND, KARIN
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
The Sox9/NFIA Transcriptional Network In Malignant Glioma
|
5K01CA190235-03
|
$140,400
|
|
GLASGOW, STACEY
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Mouse Model of DNMT3A-Associated Hematologic Malignancy
|
5R01CA183252-04
|
$533,845
|
|
GOODELL, MARGARET
|
BAYLOR COLLEGE OF MEDICINE
|
|
DEFINING THE ROLE OF DOT1L IN DNMT3A-MUTANT LEUKEMIA
|
1K08CA201611-01A1
|
$162,148
|
|
RAU, RACHEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
ESTABLISHING A CONDITIONAL TELOMERASE KNOCK-IN ALLELE IN A HAPLOID CANCER CELL LINE TO IDENTIFY REGULATORS OF ALT THROUGH GENETIC FORWARD SCREENS
|
5R21CA198701-02
|
$172,369
|
|
SAHIN, ERGUN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Discovering genetic networks of triple-negative breast cancer
|
5R01CA178039-05
|
$324,738
|
|
WESTBROOK, THOMAS
|
BAYLOR COLLEGE OF MEDICINE
|
|
Menopausal transition - a window of susceptibility for the promotion of breast ca
|
U01ES026137-03
|
$250,000
|
|
Chen, Shiuan
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Targeted activation of autoimmune checkpoints in B cell malignancies
|
7R01CA157644-08
|
$410,875
|
$410,875
|
M?SCHEN, MARKUS
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S1
|
$73,297
|
$1,466
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S2
|
$124,999
|
$2,500
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
5P30CA033572-34
|
$2,446,682
|
$48,934
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
DNA Damage Response and Oncogenic Signaling
|
5T32CA186895-02
|
$191,581
|
|
SHEN, BINGHUI
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
In situ Imaging of CAR T-cells
|
5R21CA193055-03
|
$258,825
|
|
WILLIAMS, JOHN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cytology-Free POC Cervical Cancer Diagnostics for Global Health
|
5UH2CA202663-02
|
$491,011
|
|
WEIDEMAIER, KRISTIN
|
BECTON, DICKINSON AND COMPANY
|
|
Androgen Receptor Action in Castration Resistant Prostate Cancer
|
5P01CA163227-05
|
$2,045,478
|
|
BALK, STEVEN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
SOX9 Mediation of AR and ERG Driven Prostate Cancer
|
5R01CA168393-04
|
$361,050
|
|
BALK, STEVEN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Elucidating Novel Akt Regulatory Mechanisms to Overcome Akt-mediated Therapeutic Resistance in Breast Cancer
|
5K99CA207867-02
|
$168,804
|
|
GAN, WENJIAN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Novel regulation of PI3K/Akt to direct targeted breast cancer therapies
|
5R01CA177910-05
|
$361,050
|
|
TOKER, ALEX
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Exploiting Metabolic Vulnerabilities in the PI3K and Akt Pathway in Cancer for Therapeutic Benefit
|
5R01CA200671-02
|
$395,738
|
|
TOKER, ALEX
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Characterizing the signaling pathways that regulate Skp2 oncogenic function
|
5R01CA200573-02
|
$395,738
|
|
WEI, WENYI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Targeting the APC/Cdc20 E3 ubiquitin ligase for chemoradiation sensitization
|
5R01CA200651-02
|
$383,385
|
|
WEI, WENYI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Lig4R278H contribution to HSC and IgH class switching defects and malignancies
|
5R01CA161151-05
|
$381,305
|
|
YAN, CATHERINE
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
The role of Jmjd1c in normal and leukemic hematopoiesis
|
5R00CA168996-05
|
$238,701
|
|
ZHU, NAN
|
BLOODCENTER OF WISCONSIN, INC.
|
|
Detection of Methylation and Translocation Events by Novel Sequencing Technology
|
1R43CA214386-01
|
$242,731
|
|
PEYTAVI, REGIS
|
BLUENOVO BIOSYSTEMS, INC.
|
|
Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma
|
5R01CA196703-03
|
$404,888
|
|
CHIARLE, ROBERTO
|
BOSTON CHILDREN'S HOSPITAL
|
|
Lymphocyte Function Associated Antigens
|
5R01CA031798-37
|
$581,719
|
|
SPRINGER, TIMOTHY
|
BOSTON CHILDREN'S HOSPITAL
|
|
Structural mechanisms underlying latency and activation of GDF8
|
5R01CA210920-02
|
$394,594
|
|
SPRINGER, TIMOTHY
|
BOSTON CHILDREN'S HOSPITAL
|
|
National Research Mentoring Network for a Diverse Biomedical Workforce
|
U54GM119023-04
|
$487,159
|
|
LUNA, RAFAEL
|
BOSTON COLLEGE
|
|
Development of a novel cell-based immune therapy using Nanoparticles and natural IgM-producing phagocytic B cells
|
5R21CA205415-02
|
$186,807
|
|
ZHONG, XUEMEI
|
BOSTON MEDICAL CENTER
|
|
Engineered Invasive Human Breast Tumors with Integrated Capillaries and Lymphatics
|
1U01CA214292-01
|
$571,159
|
|
TIEN, JOE
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
Why red-haired individuals are so prone to developing melanoma
|
5R01CA196896-03
|
$374,464
|
|
CUI, RUTAO
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
The Role of DLST in Leukemogenesis
|
1R56CA215059-01
|
$376,294
|
|
FENG, HUI
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Accelerating Cancer Genomics with Cloud-scale Bioconductor
|
1U01CA214846-01
|
$458,029
|
|
CAREY, VINCENT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Transforming the diagnosis and care of patients with CTCL using TCR sequencing
|
5R01CA203721-02
|
$680,545
|
|
CLARK, RACHAEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
CRISPR/Cas9-based lineage tracing for fate mapping of cancer cells and stem cells
|
5R21CA205825-02
|
$207,365
|
|
LI, ZHE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Analyzing Complex Cancer Studies With Skewed Responses
|
5R03CA205018-02
|
$83,299
|
|
LIPSITZ, STUART
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
The Tribbles-COP1 Complex in Leukemia
|
5K08CA166227-05
|
$178,200
|
|
ULJON, SACHA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
Total relevant funding to Autoimmune Diseases for this search: $8,128,980
|